Philippines President Orders Prices Of Five ‘Essential Drugs' Cut In Half
This article was originally published in PharmAsia News
Executive Summary
The Philippines president ordered a cap on the prices of five types of drugs deemed essential, with the effect of cutting the prices in half as of Aug. 15. The action had been recommended after drug makers failed to lower the prices of the five drugs on their own while agreeing to cut them on another 16 on the government's list. The industry also volunteered to cut prices of some drugs not on the list and said the order by President Gloria Macapagal Arroyo was not the best way to get essential drugs to The Philippines' poor. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.